Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID4284 | AMGIMNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4287 | AMGIMNSFVNDIFERIAGEAS | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5068 | FVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5072 | FVNDIFERIAGEASRLA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5162 | GIMNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5501 | IMNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5899 | LKQVHPDTGISSKAMGI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5902 | LKQVHPDTGISSKAMGIMNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6182 | MGIMNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6207 | MNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6209 | MNSFVNDIFERIA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6212 | MNSFVNDIFERIAGEA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6214 | MNSFVNDIFERIAGEAS | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6216 | MNSFVNDIFERIAGEASRL | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6218 | MNSFVNDIFERIAGEASRLA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6258 | NDIFERIAGEASRLA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6332 | NSFVNDIFERI | Histone H2B type 1-K | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6335 | NSFVNDIFERIAGEASRLA | Histone H2B type 1-K | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6680 | RLLLPGELAKH | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6683 | RLLLPGELAKHAV | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6685 | RLLLPGELAKHAVSEGTK | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6688 | RLLLPGELAKHAVSEGTKAV | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6691 | RLLLPGELAKHAVSEGTKAVT | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6694 | RLLLPGELAKHAVSEGTKAVTKY | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6696 | RLLLPGELAKHAVSEGTKAVTKYTS | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6700 | RLLLPGELAKHAVSEGTKAVTKYTSSK | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6826 | SFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6829 | SFVNDIFERIAGEASRLA | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7096 | SSKAMGIMNSFVNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7204 | SVYVYKVLKQVHPDTGISSKAMGI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7962 | VNDIFERI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7981 | VRLLLPGELAKHAV | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7984 | VRLLLPGELAKHAVSEGTKAV | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID7987 | VRLLLPGELAKHAVSEGTKAVTKY | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8104 | VYKVLKQVHPDTGISSKAMGI | Histone H2B type 1-C/E/F/G/I | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID9772 | PEPAKSAPAPK | Histone H2B type 1-C/E/F/G/I | Serum | 546.8 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID11321 | AVTKYTSSK | Histone H2B type 1-C/E/F/G/I | Serum | NA | LC-MS | Melanoma | "Present in 1 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11460 | GEASRLAHY | Histone H2B type 1-C/E/F/G/I | Serum | 1002.4883 | LC-MS | Melanoma | "Present in 7 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11467 | GELAKHAV | Histone H2B type 1-C/E/F/G/I | Serum | NA | LC-MS | Melanoma | "Present in 3 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID13120 | KAMGIMNSF | Histone H2B type 1-C/E/F/G/I | Plasma | 998.48 | ?LC-MS | "Multiple myeloma patients, Acute myeloid leukemia" | NA | 20974924 |